A federal jury in Boston awarded Brigham and Women’s Hospital $10.2 million in damages after deciding Perrigo’s generic version of Pepcid Complete Antacid infringed upon a pharmaceutical patent owned by Brigham and Women’s Hospital and Investor Bio-Tech LP. The infringement was deemed willful.

Plaintiff, Brigham and Women’s Hospital, Inc. is represented by James Bollinger, Daniel Ladow, Timothy Heaton, and Phoenix Pak at Troutman Sanders LLP. Impact Trial’s Kerry Cashman, Alison Von Dollen, Brittany Peters and Leah Tran provided the trial team with visual communication support during the trial.

Brigham and Women’s Hospital, Inc. et al. v. Perrigo Company, et al., 1:13-cv-11640, U.S. District Court – District of Massachusetts.